Antioxidant activity in sdg metabolites

Details Antioxidant activity in sdg metabolites Antioxidant activity in sdg metabolites

A - Human Necessities

61

K

A61K 31/365 (2006.01) A61K 31/05 (2006.01) A61K 31/09 (2006.01)

Patent

CA 2312164

The compounds secoisolariciresinol (SECO), enterodiol (ED) and enterolactone (EL), which are metabolites of secoisolariciresinol diglucoside obtained from flaxseed, are used for the treatment of diseases or conditions requiring administration of an antioxidant. Diseases or conditions that may be treated include hypercholesterolemic atherosclerosis, type I and type II -diabetes, ischemic heart disease, heart failure, endotoxic and hemmorhagic shock, inflammatory bowel disease, rheumatoid arthritis, Parkinson's disease, and stroke.

Affiliated with

Also associated with

Rating

Antioxidant activity in sdg metabolites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antioxidant activity in sdg metabolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antioxidant activity in sdg metabolites will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1696980